Branded

PARSIPPANY, N.J. — Three independent proxy advisory firms are recommending that Actavis shareholders vote in favor of the company's proposed acquisition of Warner Chilcott.

Actavis said Thursday that Institutional Shareholder Services, Glass Lewis and Egan-Jones had issued the recommendation regarding the $8.5 billion acquisition of Ireland-based Warner Chilcott, announced in May.

NEW YORK — The global market for drug packaging is expected to experience tremendous growth over the next few years, according to a new report.

FORT WORTH, Texas — The Food and Drug Administration has approved a drug made by Galderma Labs for treating a side effect of rosacea in adults, the company said.

Galderma announced the approval of Mirvaso (brimonidine) topical gel in the 0.33% strength for the topical treatment of facial erythema of rosacea. The drug is applied once per day to reduce redness and lasts up to 12 hours. The company expects the drug to become available in pharmacies next month.

HONOLULU — A company that has developed an edible security platform for addressing the global problem of counterfeit foods and medicines has been named a 2014 Technology Pioneer by the World Economic Forum.

LAKE FOREST, Ill. — Akorn on Monday morning announced its proposed acquisition of Hi-Tech Pharmacal for $640 million in cash.

WASHINGTON — The National Council on Aging on Tuesday announced that actor Lee Majors is joining the Council's Flu + You program to help encourage seniors to get their annual flu shots. As a part of his involvement in the Flu + You campaign, Majors will appear in a public service announcement that follows him as he embarks on "an important and action-packed mission: learning about his vaccine options and getting vaccinated against the flu."

LONDON — AstraZeneca has bought Maryland-based biotech company Amplimmune, the drug maker said.

AstraZeneca announced the acquisition of privately owned Amplimmune through its MedImmune biologics research and development subsidiary, saying it would boost its cancer drug pipeline. Amplimmune's pipeline includes several experimental treatments, such as AMP-514, a monoclonal antibody currently in preclinical development for which the company hopes to apply to start clinical trials before the end of the year.

MALVERN, Pa. — The Food and Drug Administration approved a new drug made by Ceptaris Therapeutics for treating a type of lymphoma, the company said Monday.